CN Patent

CN101137414A — 多环双酰胺mmp抑制剂

Assigned to Alantos Pharmaceuticals Holding Inc · Expires 2008-03-05 · 18y expired

What this patent protects

本发明总地涉及含有双酰胺基团的药物，具体说，涉及多环双酰胺MMP－13抑制剂化合物。更具体说，本发明提供了一类新的MMP－13抑制性化合物，其含有嘧啶基双酰胺基团以及杂环部分，与目前已知的含有双酰胺基团的MMP抑制剂相比，它的功效和溶解度增加。

USPTO Abstract

本发明总地涉及含有双酰胺基团的药物，具体说，涉及多环双酰胺MMP－13抑制剂化合物。更具体说，本发明提供了一类新的MMP－13抑制性化合物，其含有嘧啶基双酰胺基团以及杂环部分，与目前已知的含有双酰胺基团的MMP抑制剂相比，它的功效和溶解度增加。

Drugs covered by this patent

Patent Metadata

Patent number: CN101137414A
Jurisdiction: CN
Classification: —
Expires: 2008-03-05
Drug substance claim: No
Drug product claim: No
Assignee: Alantos Pharmaceuticals Holding Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.